# ProA Study: ProActive Management Model in Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated by Apalutamide

> **NCT06865547** · — · ENROLLING_BY_INVITATION · sponsor: **Yonghong Li** · enrollment: 94 (estimated)

## Conditions studied

- Prostate Cancer (Adenocarcinoma)

## Interventions

- **BEHAVIORAL:** The 4A ProActive Management Model

## Key facts

- **NCT ID:** NCT06865547
- **Lead sponsor:** Yonghong Li
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-01-22
- **Primary completion:** 2026-01-30
- **Final completion:** 2026-08-30
- **Target enrollment:** 94 (ESTIMATED)
- **Last updated:** 2025-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06865547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06865547, "ProA Study: ProActive Management Model in Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated by Apalutamide". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06865547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*